Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Synthesis and biological activity of new diazenedicarboxamides as potential anticancer agents (CROSBI ID 200704)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Vajs, Jure ; Soviček, Sanja ; Kureljak, Petra ; Stojanović, NIkolina ; Steiner, Ivana ; Eljuga, Domagoj ; Urankar, Damijana ; Kočevar, Marijan ; Košmrlj, Janez ; Polanc, Slovenko et al. Synthesis and biological activity of new diazenedicarboxamides as potential anticancer agents // Acta chimica slovenica, 60 (2013), 4; 842-852

Podaci o odgovornosti

Vajs, Jure ; Soviček, Sanja ; Kureljak, Petra ; Stojanović, NIkolina ; Steiner, Ivana ; Eljuga, Domagoj ; Urankar, Damijana ; Kočevar, Marijan ; Košmrlj, Janez ; Polanc, Slovenko ; Osmak, Maja

engleski

Synthesis and biological activity of new diazenedicarboxamides as potential anticancer agents

To increase the effectiveness of cancer treatment, more effective anti-cancer drugs, as well as the new improved strategies of cancer treatment, are urgently needed. Our previous results have shown that various diazenes are cytotoxic to different tumor cells and can even revert the resistance to cisplatin and vincristine. We also demonstrated that unsymmetrical diazenedicarboxamides 1 and 2 exhibited promising cytotoxicity. The aim of the present study was to synthesize new diazenedicarboxamides with acceptable solubility and good cytotoxicity. Here we report the synthesis and biological evaluation of new N, N’-disubstituted diazenedicarboxamides. We found that a modification of either 1 or 2 led to the more active compounds. The most effective among them was diazenedicarboxamide 11, which can be considered as a new potential anticancer agent for the tumors of different origin, as well as for the drug resistant tumors.

diazenedicarboxamides; tumor cells; anticancer drugs

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

60 (4)

2013.

842-852

objavljeno

1318-0207

Povezanost rada

Biologija

Indeksiranost